Rights and permissions
About this article
Cite this article
Can we afford to ignore the newer anticonvulsants?. Inpharma Wkly. 1153, 3 (1998). https://doi.org/10.2165/00128413-199811530-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199811530-00003